BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29075151)

  • 1. Sporadic
    Hayashi T; Yamashita T; Okada H; Nio K; Hara Y; Nomura Y; Hayashi T; Asahina Y; Yoshida M; Oishi N; Sunagozaka H; Takatori H; Honda M; Kaneko S
    Cancer Cell Int; 2017; 17():94. PubMed ID: 29075151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
    Zhang W; He H; Zang M; Wu Q; Zhao H; Lu LL; Ma P; Zheng H; Wang N; Zhang Y; He S; Chen X; Wu Z; Wang X; Cai J; Liu Z; Sun Z; Zeng YX; Qu C; Jiao Y
    Gastroenterology; 2017 Jul; 153(1):249-262.e2. PubMed ID: 28363643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma.
    Sung JJ; Noh SJ; Bae JS; Park HS; Jang KY; Chung MJ; Moon WS
    J Pathol Transl Med; 2016 Jan; 50(1):52-7. PubMed ID: 26581206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells.
    Nagahara T; Shiraha H; Sawahara H; Uchida D; Takeuchi Y; Iwamuro M; Kataoka J; Horiguchi S; Kuwaki T; Onishi H; Nakamura S; Takaki A; Nouso K; Yamamoto K
    Oncol Rep; 2015 Sep; 34(3):1169-77. PubMed ID: 26165819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
    Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial cell adhesion molecule in human hepatocellular carcinoma cell lines: a target of chemoresistence.
    Li Y; Farmer RW; Yang Y; Martin RC
    BMC Cancer; 2016 Mar; 16():228. PubMed ID: 26984381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients.
    Khosla R; Rastogi A; Ramakrishna G; Pamecha V; Mukhopadhyay A; Vasudevan M; Sarin SK; Trehanpati N
    Stem Cells Transl Med; 2017 Mar; 6(3):807-818. PubMed ID: 28176469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
    Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
    Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
    Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenetic initiation contributed by EpCAM+ cancer cells in orthotopic HCC models of immunocompetent and athymic mice.
    Pandit H; Li Y; Zheng Q; Guo W; Yu Y; Li S; Martin RCG
    Oncotarget; 2020 Jun; 11(22):2047-2060. PubMed ID: 32547703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM
    Moustafa M; Dähling KK; Günther A; Riebandt L; Smit DJ; Riecken K; Schröder C; Zhuang R; Krech T; Kriegs M; Fehse B; Izbicki JR; Fischer L; Nashan B; Li J; Jücker M
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC Cells.
    Tsui YM; Ho DW; Sze KM; Lee JM; Lee E; Zhang Q; Cheung GC; Tang CN; Tang VW; Cheung ET; Lo IL; Chan AC; Cheung TT; Oi-Lin Ng I
    Cell Mol Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38750898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen Receptor Enhances the Efficacy of Sorafenib Against Hepatocellular Carcinoma Through Enriched EpCAM Stemness.
    Lai HC; Chung WM; Chang CM; Liao PY; Su YT; Yeh CC; Jeng LB; Ma WL; Chang WC
    Anticancer Res; 2020 Mar; 40(3):1285-1295. PubMed ID: 32132025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De Novo Emergence of Mesenchymal Stem-Like CD105
    Nomura Y; Yamashita T; Oishi N; Nio K; Hayashi T; Yoshida M; Hayashi T; Hashiba T; Asahina Y; Okada H; Sunagozaka H; Takatori H; Honda M; Kaneko S
    Transl Oncol; 2017 Apr; 10(2):184-189. PubMed ID: 28182993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.
    Nwosu ZC; Battello N; Rothley M; Piorońska W; Sitek B; Ebert MP; Hofmann U; Sleeman J; Wölfl S; Meyer C; Megger DA; Dooley S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):211. PubMed ID: 30176945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.
    Matthai SM; Ramakrishna B
    Indian J Med Res; 2015 Oct; 142(4):391-8. PubMed ID: 26609030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma.
    Matsumoto T; Takai A; Eso Y; Kinoshita K; Manabe T; Seno H; Chiba T; Marusawa H
    Cancer Res; 2017 Nov; 77(22):6131-6143. PubMed ID: 28951464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Search for the potential "second-hit" mechanism underlying the onset of familial hemophagocytic lymphohistiocytosis type 2 by whole-exome sequencing analysis.
    Gao L; Dang X; Huang L; Zhu L; Fang M; Zhang J; Xu X; Zhu L; Li T; Zhao L; Wei J; Zhou J
    Transl Res; 2016 Apr; 170():26-39. PubMed ID: 26739415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.